Page last updated: 2024-11-07

penicillamine and Absence Status

penicillamine has been researched along with Absence Status in 3 studies

Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berger, B1
Mader, I1
Damjanovic, K1
Niesen, WD1
Stich, O1
Türk-Börü, U1
Kocer, A1
Alp, R1
Gümüş, M2
Yoshida, K1
Maruyama, K1
Hashimoto, T1
Shindo, M1
Shoji, S1
Yanagisawa, N1

Other Studies

3 other studies available for penicillamine and Absence Status

ArticleYear
Epileptic status immediately after initiation of D-penicillamine therapy in a patient with Wilson's disease.
    Clinical neurology and neurosurgery, 2014, Volume: 127

    Topics: Adult; Chelating Agents; Copper; Female; Hepatolenticular Degeneration; Humans; Magnetic Resonance I

2014
Status epilepticus in a case with wilson's disease during D-pencillamine treatment.
    Swiss medical weekly, 2003, Aug-09, Volume: 133, Issue:31-32

    Topics: Adult; Cerebral Cortex; Electroencephalography; Hepatolenticular Degeneration; Humans; Magnetic Reso

2003
[A case of Wilson's disease who developed status epilepticus during D-penicillamine therapy].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1989, Volume: 78, Issue:1

    Topics: Adolescent; Cerebral Cortex; Female; Hepatolenticular Degeneration; Humans; Penicillamine; Status Ep

1989